| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 80,822 | 76,643 | 76,316 | 95,068 | | Cost of Revenue | 61,147 | 58,110 | 61,847 | 71,068 | | | Gross Profit | 19,675 | 18,533 | 14,469 | 24,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 16,965 | 17,450 | 18,556 | 16,930 | | Non Recurring | 1,480 | 11,602 | 4,798 | 49,156 | | Others | 123 | 119 | 114 | 518 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,017 | (10,638) | (8,999) | (42,604) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (150) | (94) | 113 | (1,030) | | Earnings Before Interest And Taxes | 957 | (10,732) | (8,886) | (43,634) | | Interest Expense | 586 | 371 | 426 | 608 | | Income Before Tax | 371 | (11,103) | (9,312) | (44,242) | | Income Tax Expense | 214 | 1,200 | 2,761 | (13,741) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 157 | (12,303) | (12,073) | (30,501) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 157 | (12,303) | (12,073) | (30,501) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $157 | ($12,303) | ($12,073) | ($30,501) |
|
0.51% Nasdaq 
Income Statement
